These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 19231068)
1. Chemokine C-X-C motif receptor 6 contributes to cell migration during hypoxia. Lin S; Sun L; Hu J; Wan S; Zhao R; Yuan S; Zhang L Cancer Lett; 2009 Jun; 279(1):108-17. PubMed ID: 19231068 [TBL] [Abstract][Full Text] [Related]
2. CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro. Lu Y; Wang J; Xu Y; Koch AE; Cai Z; Chen X; Galson DL; Taichman RS; Zhang J Mol Cancer Res; 2008 Apr; 6(4):546-54. PubMed ID: 18344492 [TBL] [Abstract][Full Text] [Related]
3. Chemokine receptor expression profiles in nasopharyngeal carcinoma and their association with metastasis and radiotherapy. Ou DL; Chen CL; Lin SB; Hsu CH; Lin LI J Pathol; 2006 Nov; 210(3):363-73. PubMed ID: 16955398 [TBL] [Abstract][Full Text] [Related]
4. Endothelins induce CCR7 expression by breast tumor cells via endothelin receptor A and hypoxia-inducible factor-1. Wilson JL; Burchell J; Grimshaw MJ Cancer Res; 2006 Dec; 66(24):11802-7. PubMed ID: 17178876 [TBL] [Abstract][Full Text] [Related]
5. Hypoxia enhances CXCR4 expression by activating HIF-1 in oral squamous cell carcinoma. Ishikawa T; Nakashiro K; Klosek SK; Goda H; Hara S; Uchida D; Hamakawa H Oncol Rep; 2009 Mar; 21(3):707-12. PubMed ID: 19212630 [TBL] [Abstract][Full Text] [Related]
6. Hypoxia/reoxygenation: a dynamic regulator of lysyl oxidase-facilitated breast cancer migration. Postovit LM; Abbott DE; Payne SL; Wheaton WW; Margaryan NV; Sullivan R; Jansen MK; Csiszar K; Hendrix MJ; Kirschmann DA J Cell Biochem; 2008 Apr; 103(5):1369-78. PubMed ID: 17685448 [TBL] [Abstract][Full Text] [Related]
7. Involvement of Escherichia coli in pathogenesis of xanthogranulomatous cholecystitis with scavenger receptor class A and CXCL16-CXCR6 interaction. Sawada S; Harada K; Isse K; Sato Y; Sasaki M; Kaizaki Y; Nakanuma Y Pathol Int; 2007 Oct; 57(10):652-63. PubMed ID: 17803654 [TBL] [Abstract][Full Text] [Related]
8. Profiles of chemokine receptors in melanocytic lesions: de novo expression of CXCR6 in melanoma. Seidl H; Richtig E; Tilz H; Stefan M; Schmidbauer U; Asslaber M; Zatloukal K; Herlyn M; Schaider H Hum Pathol; 2007 May; 38(5):768-80. PubMed ID: 17306330 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of CXCL16 and its receptor CXCR6/Bonzo promotes growth of human schwannomas. Held-Feindt J; Rehmke B; Mentlein R; Hattermann K; Knerlich F; Hugo HH; Ludwig A; Mehdorn HM Glia; 2008 May; 56(7):764-74. PubMed ID: 18293410 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of CXCL16/CXCR6 expression in patients with prostate cancer. Ha HK; Lee W; Park HJ; Lee SD; Lee JZ; Chung MK Mol Med Rep; 2011; 4(3):419-24. PubMed ID: 21468586 [TBL] [Abstract][Full Text] [Related]
11. CXCR6-CXCL16 interaction in the pathogenesis of Juvenile Idiopathic Arthritis. Martini G; Cabrelle A; Calabrese F; Carraro S; Scquizzato E; Teramo A; Facco M; Zulian F; Agostini C Clin Immunol; 2008 Nov; 129(2):268-76. PubMed ID: 18760678 [TBL] [Abstract][Full Text] [Related]
12. Hypoxia-induced matrix metalloproteinase-13 expression in astrocytes enhances permeability of brain endothelial cells. Lu DY; Yu WH; Yeh WL; Tang CH; Leung YM; Wong KL; Chen YF; Lai CH; Fu WM J Cell Physiol; 2009 Jul; 220(1):163-73. PubMed ID: 19241444 [TBL] [Abstract][Full Text] [Related]
13. Chemokine CXCL16, a scavenger receptor, induces proliferation and invasion of first-trimester human trophoblast cells in an autocrine manner. Huang Y; Zhu XY; Du MR; Wu X; Wang MY; Li DJ Hum Reprod; 2006 Apr; 21(4):1083-91. PubMed ID: 16431903 [TBL] [Abstract][Full Text] [Related]
14. Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma. Wente MN; Gaida MM; Mayer C; Michalski CW; Haag N; Giese T; Felix K; Bergmann F; Giese NA; Friess H Int J Oncol; 2008 Aug; 33(2):297-308. PubMed ID: 18636150 [TBL] [Abstract][Full Text] [Related]
15. Hypoxia enhances MUC1 expression in a lung adenocarcinoma cell line. Mikami Y; Hisatsune A; Tashiro T; Isohama Y; Katsuki H Biochem Biophys Res Commun; 2009 Feb; 379(4):1060-5. PubMed ID: 19141292 [TBL] [Abstract][Full Text] [Related]
16. CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms. Xiao G; Wang X; Wang J; Zu L; Cheng G; Hao M; Sun X; Xue Y; Lu J; Wang J Oncotarget; 2015 Jun; 6(16):14165-78. PubMed ID: 25909173 [TBL] [Abstract][Full Text] [Related]
17. CCL21 promotes the migration and adhesion of highly lymph node metastatic human non-small cell lung cancer Lu-99 in vitro. Koizumi K; Kozawa Y; Ohashi Y; Nakamura ES; Aozuka Y; Sakurai H; Ichiki K; Doki Y; Misaki T; Saiki I Oncol Rep; 2007 Jun; 17(6):1511-6. PubMed ID: 17487412 [TBL] [Abstract][Full Text] [Related]
18. STAT1 represses hypoxia-inducible factor-1-mediated transcription. Hiroi M; Mori K; Sakaeda Y; Shimada J; Ohmori Y Biochem Biophys Res Commun; 2009 Oct; 387(4):806-10. PubMed ID: 19646959 [TBL] [Abstract][Full Text] [Related]
19. Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells. Ludwig A; Schulte A; Schnack C; Hundhausen C; Reiss K; Brodway N; Held-Feindt J; Mentlein R J Neurochem; 2005 Jun; 93(5):1293-303. PubMed ID: 15934948 [TBL] [Abstract][Full Text] [Related]
20. Chemokine C-C motif receptor 5 and C-C motif ligand 5 promote cancer cell migration under hypoxia. Lin S; Wan S; Sun L; Hu J; Fang D; Zhao R; Yuan S; Zhang L Cancer Sci; 2012 May; 103(5):904-12. PubMed ID: 22380870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]